吲哚布芬联合智能个体化抗阻训练对 ACS 患者支架术后血小板功能及心血管预后的影响研究

Effect of indobufen combined with intelligent individualized resistance training on platelet function and cardiovascular prognosis after stent implantation in patients with acute coronary syndrome

:-
 
目的 探讨吲哚布芬联合智能抗阻训练对急性冠脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)术后血小板功能及心功能的影响。方法 选取2024年1月至2025年12月在本院接受PCI支架植入术的60例ACS患者,随机分为观察组和对照组,每组30例。对照组给予常规治疗联合氯吡格雷75 mg/d治疗,观察组给予常规治疗联合吲哚布芬(100mg/次,2次/d)+智能抗阻训练干预,两组均连续干预3个月。比较两组患者干预前、干预1个月、3个月时花生四烯酸(AA)诱导和二磷酸腺苷(ADP)诱导的血小板聚集率,随访3个月不良心血管事件(MACE)发生率,以及干预前后心功能指标[左心室射血分数(LVEF)、左心室舒张末期内径(LVEDD)]。结果 干预前两组血小板聚集率、LVEF、LVEDD比较差异无统计学意义(P>0.05);干预1个月、3个月时,观察组AA诱导和ADP诱导的血小板聚集率降低幅度均显著大于对照组(P<0.05);干预3个月后,观察组LVEF显著高于对照组,LVEDD显著低于对照组(P<0.05);随访3个月,两组MACE发生率比较差异无统计学意义(P>0.05)。结论 吲哚布芬联合智能抗阻训练可更显著地抑制ACS患者PCI术后血小板聚集,更有效地改善心功能指标,且安全性良好。
Objective To explore the effect of indobufen combined with intelligent resistance training on platelet function and cardiac function in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). Methods A total of 60 ACS patients who underwent PCI stent implantation in our hospital from January 2024 to December 2025 were selected and randomly divided into an observation group and a control group, with 30 patients in each group. The control group was given conventional treatment combined with clopidogrel 75 mg/d, while the observation group was given conventional treatment combined with indobufen (100 mg/time, twice a day) + intelligent resistance training intervention. Both groups received continuous intervention for 3 months. The arachidonic acid (AA)-induced and adenosine diphosphate (ADP)-induced platelet aggregation rates were compared between the two groups before intervention, 1 month and 3 months after intervention. The incidence of major adverse cardiovascular events (MACE) was followed up for 3 months, and the cardiac function indexes [left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD)] were compared before and after intervention. Results Before intervention, there were no significant differences in platelet aggregation rates, LVEF and LVEDD between the two groups (P > 0.05); at 1 month and 3 months after intervention, the reduction amplitudes of AA-induced and ADP-induced platelet aggregation rates in the observation group were significantly greater than those in the control group (P < 0.05); after 3 months of intervention, LVEF in the observation group was significantly higher than that in the control group, and LVEDD was significantly lower than that in the control group (P < 0.05); after 3 months of follow-up, there was no significant difference in the incidence of MACE between the two groups (P > 0.05). Conclusion Indobufen combined with intelligent resistance training can more significantly inhibit platelet aggregation, more effectively improve cardiac function indexes in ACS patients after PCI, and has good safety.
论著

富血小板血浆联合自体脂肪在大阴唇填充手术中的应用

Application of platelet-rich plasma combined with autologous fat in labia majora filling surgery

:64-67
 
目的 探讨富血小板血浆联合自体脂肪在大阴唇填充手术中的治疗效果。方法 选择2021年1月—12月在南昌大学第一附属医院整形外科就诊、希望通过自体脂肪移植技术改善大阴唇外观的23例女性患者,年龄23~59 岁,平均年龄(45.23±1.42)岁。依据术前与患者沟通的手术效果,将富血小板血浆和脂肪组织混合并进行注射填充;并分别使用GAIS评价量表、Likert评估量表及 FSFI问卷评估手术效果。结果 每例患者每侧大阴唇的注射量为20~35 mL,术后即刻效果均非常满意,未出现感染、血肿等术后并发症。术后6个月随访,所有患者大阴唇形态符合美学标准;GAIS 评价结果显示,完全改善率达82.61%,明显改善率为13.04%,轻度改善率为 4.35%;阴唇术后效果的满意情况显示,非常满意占86.96%,满意占13.04%,无不满意或非常不满意者;6个月后患者的平均FSFI评分(53.81分)高于术前(31.80分,P<0.001)。结论 富血小板血浆联合自体脂肪注射填充可纠正大阴唇容量缺损,临床疗效良好。
Objective To investigate the therapeutic effect of platelet-rich plasma combined with autologous fat in labia majora filling surgery.Methods From January to December 2021,23 female patients,aged 23-59,with an average age of(45.23±1.42),were admitted to the Plastic Surgery Department of the First Affiliated Hospital of Nanchang University,hoping to improve the appearance of the labia major through autologous fat transplantation technology.According to the results of preoperative communication with the patient,platelet-rich plasma and adipocytes were mixed and injected to fill the labia majora.GAIS evaluation scale,Likert evaluation scale and FSFI questionnaire were used to evaluate the surgical effect.Results The injection amount of each side of labia majora in all patients was 20~35 mL,the immediate postoperative effect was very satisfactory,and there were no postoperative complications such as infection and hematoma.After 6 months of follow-up,all patients' labia majora morphology met the aesthetic standard.GAIS evaluation results showed that the complete improvement rate was 82.61%,the obvious improvement rate was 13.04%,and the mild improvement rate was 4.35%.The satisfaction of labial postoperative results showed that 86.96% of patients were very satisfied and 13.04% were satisfied,no dissatisfied or very dissatisfied.Six months afterwards,the patients' mean total FSFI score(53.81)was significantly higher than that of preoperation(31.8,P<0.001).Conclusions Platelet-rich plasma combined with autologous fat injection can correct the labia majora volume defect and obtain satisfactory clinical effect.
论著

富血小板血浆联合关节镜治疗Ⅲ度半月板损伤膝关节功能恢复时间的影响因素分析

Analysis of influencing factors on the recovery time of knee joint function in the treatment of third-degree meniscus injury with platelet rich plasma combined with arthroscopy

:673-679
 
目的 探讨富血小板血浆(PRP)联合关节镜治疗Ⅲ度半月板损伤患者的临床疗效,及其对膝关节功能恢复时间的影响。方法 选取2021年2月—2022年2月南方医科大学南方医院增城院区骨科收治的Ⅲ度半月板损伤患者45例,采用随机数字法分为观察组22例与对照组23例,对照组患者在关节镜下行半月板成形术,观察组在对照组基础上给予PRP治疗。观察两组患者术后恢复时间、治疗效果及并发症发生情况;比较两组治疗前和治疗后1、3、6个月膝关节功能、疼痛情况。结果 利用观察组患者自体全血制备的PRP,其血小板的回收率、红细胞留存率、白细胞留存率分别为(91.00±9.27)%、(0.29±0.12)%、(29.98±6.68)%,PRP制备质量稳定、可控。观察组联合PRP治疗术与关节镜手术治疗后恢复时间均短于对照组,观察组治疗有效率高于对照组(P<0.05)。经重复方差测量分析,两组美国特种外科医院膝关节评分系统(HSS)评分、西安大略大学和麦克马斯特大学骨关节炎指数(WOMAC)评分、视觉模拟疼痛评分法(VAS)交互(F交互=1.869、F交互=1.482、F交互=2.193)比较差异均有统计学意义(P<0.05);与对照组治疗后1、3、6个月比较,观察组HSS评分升高,WOMAC评分、VAS评分下降(P<0.05);观察组并发症总发生率4.55%低于对照组30.43%(χ2=5.156、P=0.023)。结论 对于Ⅲ度半月板损伤患者,采用PRP联合关节镜手术治疗可帮助患者消炎止痛、加快疗效、加快膝关节功能的恢复,缩短其恢复的时间,效果良好,且安全性较高。
Objective To investigate the clinical effect of platelet rich plasma(PRP)combined with arthroscopy treatment on patients with third degree meniscus injury,and its impact on the recovery time of knee joint function.Methods From February 2021 to February 2022,45 patients with III-degree meniscal injuries admitted to the Department of Orthopedics,Zengcheng district,Nanfang Hospital of Southern Medical University were selected and divided into an observation group of 22 cases and a control group of 23 cases using the random number method.Patients in the control group received menisplasty under arthroscopy,and the observation group was given PRP treatment on the basis of the control group.The postoperative recovery time,treatment effects and complications of the two groups of patients were observed;the knee joint function and pain of the two groups before treatment and 1,3,and 6 months after treatment were compared.Results The platelet recovery rate,red blood cell retention rate,and white blood cell retention rate of PRP prepared from the autologous whole blood of patients in the observation group were(91.00±9.27)%,(0.29±0.12)%,and(29.98±6.68)% respectively.The PRP preparation quality is stable and controllable.The recovery time after combined PRP treatment and arthroscopic surgery in the observation group was shorter than that in the control group,and the treatment effectiveness of the observation group was higher than that of the control group(P<0.05).After repeated measures of variance analysis,the comparison of American Hospital for Special Surgery(HSS)Knee Scoring System,Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC),and visual analogue pain scales(VAS)interacted(FInteraction=1.869,Finteraction=1.482,Finteraction=2.193),the differences were statistically significant(P<0.05).Compared with the control group 1,3,and 6 months after treatment,the HSS score of the observation group increased,and the WOMAC score,VAS score decreased(P<0.05);the total incidence of complications in the observation group was 4.55%,lower than that in the control group(30.43%,χ2=5.156,P=0.023).Conclusions For patients with III-degree meniscal injuries,PRP combined with arthroscopic surgery can help reduce inflammation and pain,speed up the curative effect,accelerate the recovery of knee joint function,and shorten the recovery time.It has good effects and is relatively safe.
专家述评

血小板药物递送系统的研究进展

Advances in platelet as drug delivery systems

:577-584
 
药物递送系统对于各类疾病意义非凡,但传统药物载体面临细胞毒性强、组织相容性低、半衰期短和靶向性弱等诸多挑战。血小板及其相关衍生物作为新型药物载体具有更为显著的优势。由于血小板自身的生理特点,以及在肿瘤、心血管疾病、血栓性疾病、感染等多种疾病中发挥的病理生理作用,血小板能够弥补传统药物载体的缺陷,具有极大的临床转化意义。该文总结了血小板相关药物递送系统目前的研究进展,以期为新型药物载体研究提供参考。
Drug delivery systems are important for various diseases,but conventional therapeutic drug have many shortcomings,such as high cytotoxicity,low histocompatibility,short half-life and weak targeting.Platelets and their derivatives have more significant advantages as novel drug carriers.Platelets play an important role in the pathophysiology of a wide range of diseases including oncology,cardiovascular diseases,thrombosis and infection.In this paper,we summarized the current research progress of platelet-related drug delivery systems to provide a reference for the research of novel drug delivery systems.
论著

血流感染患者血小板参数动态变化及其预后价值

:1066-1071
 
目的 分析血流感染(BSI)患者血小板参数的动态变化及其在患者预后中的价值。方法 回顾性分析南通市中西医结合医院检验科明确BSI的66例患者,分为生存组(55例)和死亡组(11例)。比较不同组间病原菌分布及1周内血小板参数动态变化情况,并通过Logistic回归分析评估血小板参数动态变化的在治疗预后评估中的价值。结果 (1)BSI患者病原菌分为革兰氏阳性菌(G+)25株、革兰氏阴性菌(G-)39株、真菌2株;G+病原菌中前三位为金黄色葡萄球菌(10.61%)、表皮葡萄球菌(7.58%)、头状葡萄球菌(4.55%);G-病原菌中前三位为大肠埃希菌(24.24%)、肺炎克雷伯菌肺炎亚种(15.15%)、肠炎沙门菌血清型(3.03%);真菌为新生隐球酵母(1.52%)、光滑假丝酵母(1.52%)。(2)生存组序贯性器官功能衰竭评分(SOFA)评分为(3.24±0.53)分,低于死亡组的(6.02±1.17)分(t=12.535,P<0.001);生存组BSI病程为(20.50±2.17)d,低于死亡组的(25.71±4.81)d(t=3.352,P<0.001);生存组肺部原发感染灶30.91%,高于死亡组的63.64%(χ2=4.243,P=0.039);生存组最大平均血小板体积(MPV)为(10.96±1.58)fL,低于死亡组的(11.99±1.42)fL(t=2.004,P=0.049);生存组入院血小板计数(PLT)为(144.33±23.18)109/L,低于死亡组的(166.91±20.29)109/L(t=3.005,P=0.004);生存组最低PLT为(113.48±30.76)109/L,高于死亡组的(80.16±38.24)109/L(t=3.148,P=0.002)。(3)两组入院及BSI时、BSI后4 d内的指标比较差异均无统计学意义(P>0.05),在BSI后的5~7 d,生存组PLT为(210.83±102.37)109/L,高于死亡组的(112.75±116.84)109/L(t=2.835,P=0.006);生存组MPV为(10.12±1.58)fL,低于死亡组的(11.27±1.85)fL(t=2.142,P=0.036);生存组MPV/PLT 比值(MPR)为(5.69±2.89),低于死亡组的(11.64±8.23)(t=4.290,P<0.001)。(4)多因素Logistic回归分析发现,入院SOFA(OR=5.461,95%CI:1.544~19.319,P=0.008)、BSI病程(OR=0.773,95%CI:0.622~0.960,P=0.020)、5~7 d MPR(OR=18.976,95%CI:1.776~202.709,P=0.015)是BSI的预测因素。结论 BSI患者血小板参数动态变化较为明显,而入院SOFA、BSI病程、5~7 d MPR对于预测患者死亡风险有重要意义。
论著

透明质酸钠注射联合富含血小板的血浆治疗膝骨关节炎患者的疗效

Efficacy of sodium hyaluronate injection combined with platelet-rich plasma in patients with knee osteoarthritis

:44-47
 
目的 探讨透明质酸钠注射联合富含血小板的血浆治疗膝骨关节炎患者的效果。方法 收集2019年7月—2021年7月在本院就诊的膝骨关节炎患者120例,采用随机数字表法分组,即对照组、观察组,均60例。对照组患者注入富含血小板的血浆(4 mL),观察组患者注射透明质酸钠(2 mL)联合富含血小板的血浆(3.5 mL),1次/周,3次为1个疗程,共2~3疗程。统计2组患者膝关节功能、临床疗效及并发症发生率。结果 ①组内比较:治疗后2月、3月及6月平均Lysholm膝关节评分均升高,P<0.05;②组间比较:治疗前及治疗后2月,2组患者平均Lysholm膝关节评分比较,P>0.05,治疗后3月、6月,2组平均Lysholm膝关节评分比较,P<0.05。2组患者Lysholm膝关节评分均较治疗前有所改善,P<0.05;观察组疼痛评分(18.92±4.11、17.61±3.83)分、肿胀度评分(10.64±2.82、9.66±1.21)分均高于对照组疼痛评分(14.02±3.52、13.54±3.21)分、肿胀度评分(9.62±2.63、8.71±1.93)分(P<0.05)。观察组临床总有效率98.33%高于对照组临床总有效率88.33%(χ2=4.821,P=0.028)。经过6个月的随访后,2组均1例出现局部肿胀,未发生其他并发症。结论 透明质酸钠注射联合富含血小板的血浆治疗膝骨关节炎患者,可以有效改善患者膝关节功能,减轻患者疼痛及肿胀程度等,安全性高,值得推广应用。
Objective To investigate the effect of sodium hyaluronate injection combined with platelet-rich plasma in the treatment of patients with knee osteoarthritis. Methods A total of 120 patients with knee osteoarthritis who were treated in our hospital from July 2019 to July 2021 were collected and randomly divided into control group and observation group,60 cases each.The patients in the control group were injected with platelet-rich plasma(4 mL),and the patients in the observation group were injected with sodium hyaluronate(2 mL)combined with platelet-rich plasma(3.5 mL),once a week,3 times as a course of treatment,total 2-3 courses of treatment.The knee joint function,clinical efficacy and complication rates of the two groups were compared. Results ①Intra-group comparison:the average Lysholm knee joint scores were significantly increased in 2 months,3 months and 6 months after treatment,P<0.05. ②Comparison between groups:before and 2 months after treatment,the average Lysholm knee joint scores of the two groups were significantly increased (P<0.05). After 3 months and 6 months treatment,the comparison of the average Lysholm knee score between the two groups were statistic significant (P<0.05).The Lysholm knee joint scores in both groups were improved compared with those before treatment (P<0.05). Three months after treatment,the pain score(18.92±4.11, 17.61±3.83)and swelling score(10.64±2.82, 9.66±1.21)in the observation group were significantly higher than those in the control group(14.02±3.52, 13.54±3.21, 9.62±2.63, 8.71±1.93, P<0.05).The total clinical effective rate of the observation group was 98.33%,which was significantly higher than that of the control group (88.33%, χ2=4.821,P=0.028).After 6-month follow-up,local swelling occurred in 1 case in both groups,and no other complications occurred. Conclusions Sodium hyaluronate injection combined with platelet-rich plasma in the treatment of patients with knee osteoarthritis can effectively improve the knee joint function and reduce the pain and swelling of the patients.It is safe and worthy of popularization and application.
论著

富血小板血浆联合髓芯减压治疗早期膝关节自发性骨坏死的疗效

Effect of platelet-rich plasma combined with core decompression in the treatment of early spontaneous osteonecrosis of the knee

:45-49
 
目的 探讨富血小板血浆(platelet-rich plasma, PRP)联合髓芯减压治疗早期膝关节自发性骨坏死(spontaneous osteonecrosis of the knee, SONK)的临床疗效。方法 回顾性分析我院2015年6月—2020年6月收治Koshino分期为Ⅰ、Ⅱ期的SONK患者,按治疗方法不同分为单纯髓芯减压组(对照组 21例)和PRP注射+髓芯减压组(PRP组 22例),比较2组患者治疗前、后1月、3月、6月、12月的VAS评分、WOMAC评分,评估术前和随访时膝关节功能,并观察记录有无并发症。结果 43例患者术后随访12~62个月,2组患者治疗后均无切口感染、关节感染、深静脉血栓等并发症。2组患者术前VAS评分、WOMAC评分比较无统计学意义(P>0.05);VAS评分、WOMAC评分在术后1、3、6 、12月较术前比较差异均有统计学意义(P<0.05);与对照组相比,PRP组术后3、6、12月的VAS评分降低(P<0.05),PRP组在术后6、12月的WOMAC评分改善(P<0.05)。PRP组、对照组的总体有效率分别为90.48%(19/21)、77.27%(17/22),差异有统计学意义(P<0.05)。在完成治疗12个月后至今的随访中,对照组共有6例患者、PRP组仅2例患者行单髁置换。结论 富血小板血浆联合髓芯减压治疗早期SONK,安全有效,临床疗效优于单纯髓芯减压术。
Objective To investigate the clinical effect of platelet-rich plasma(PRP) combined with core decompression in the treatment of early spontaneous osteonecrosis of the knee(SONK). Methods A retrospective analysis of SONK patients with Koshino stage I and Ⅱ admitted to our hospital from June 2015 to June 2020 was carried out. According to the different treatment methods, patients were divided into core decompression group (control group, 21 patients), and knee joint cavity PRP injection combined with core decompression group (PRP group, 22 patients). The VAS scores and WOMAC scores before treatment, 1, 3, 6 and 12 months after surgery were compared between the two groups to assess the knee joint function, and observed whether there were complications. Results Forty-three patients were followed up for 12 to 62 months after the operation. After treatment, the two groups had no complications such as wound infection, joint infection, or deep vein thrombosis. The preoperative VAS score and WOMAC score of the two groups were not significantly different (P>0.05);compared with those before the operation, VAS score and WOMAC score were significantly different at 1, 3, 6, and 12 months after the operation (P<0.05); compared with the control group, the VAS score of the PRP group was significantly reduced at 3, 6, and 12 months after surgery (P<0.05), and the WOMAC score of the PRP group was significantly improved at 6 and 12 months after surgery (P<0.05). The overall effective rates of the PRP group and the control group were 90.48% (19/21) and 77.27% (17/22) respectively, and the difference between the two groups was statistically significant (P<0.05). In the follow-up 12 months after the completion of the treatment, 6 patients in the control group and 2 patients in the PRP group underwent unicondylar replacement. Conclusion The combination of platelet-rich plasma and core decompression in the treatment of early SONK was safe and effective, and the clinical effect was better than that of core decompression only.
临床诊疗

β-地中海贫血患儿血小板参数显示不全原因分析

:138-140
 
目的 探讨Sysmex-2100全自动血液分析仪检测β-地中海贫血(β-地贫)患儿血小板参数显示不全的原因。方法 收集2017年4月—2020年4月期间本院确诊β-地贫患儿301人,其中重型病例204例,非重型97例。对301例患儿均采用希森美康Sysmex-2100血细胞分析仪进行血细胞分析,标本制作血涂片充分干燥后经瑞氏-吉姆萨染色,由主管技师及以上检验人员进行人工镜检。结果 301例β-地贫患儿血细胞分析结果出现血小板参数不显示者102例,占33.89%;其中有小红细胞、红细胞碎片、血小板聚集97例(95.10%);血小板直方图异常93例(91.18%)。重型β-地贫患儿血小板参数显示不全者75例,非重型β-地贫患儿血小板参数显示不全者27例,两组间血小板参数显示不全比例差异无统计学意义(P= 0.126)。血小板参数全显示病例的平均红细胞体积高于血小板参数显示不全病例,差异有统计学意义(P< 0.0001)。结论 小细胞低色素性红细胞及红细胞碎片化是β-地贫患儿血小板参数显示不全的主要原因,通过血小板直方图正常与否可大致判断血小板参数的可信度,采用PLT-O通道检测及涂片镜检查找原因,可提高结果的准确性。
论著

河源地区机采血小板固定献血者血小板抗原系统基因多态性分析

The polymorphism of human platelet antigens in fixed apheresis platelet donors in Heyuan area

:64-67
 
目的 探讨河源地区机采血小板固定献血者血小板抗原系统的基因多态性特征,为建立本地区机采血小板供血者库奠定基础。方法 采用PCR-SSP方法对100例机采血小板固定献血者进行血小板抗原HPA1~17系统基因分型。结果 HPA1~17基因中成多态性分布的等位基因是HPA2a、HPA3a、HPA5a、HPA15a,其频率分别为0.96、0.49、0.99、0.515。HPA-2、HPA-3、HPA-5、HPA-15系统存在aa、ab、bb 三种表型。HPA1a、HPA4a、HPA6a-14a、HPA16a-17a基因频率为1,呈单线性分布,未发现b基因。结论 河源地区血小板HPA-3系统不配合率最高(0.420),HPA-15系统次之。建立本地区机采血小板供血者库,为患者提供HPA相合的血小板,对减少临床血小板输注无效的发生具有重要意义。
Objective To study the polymorphism of human platelet antigens in fixed apheresis platelet donors in Heyuan area and to lay a foundation for the establishment of platelets donor bank. Methods PCR-SSP method was used to analyze HPA 1~17 genotype in 100 fixed platelet donors. Results The highest numbers of heterozygotes were HPA2a,HPA3a,HPA5a and HPA15a,with frequencies of 0.96,0.49,0.99 and 0.515,respectively. The frequencies of HPA1a,HPA4a,HPA6a-14a and HPA16a-17a genes were 1,which showed a single linear distribution. Conclusion HPA-3 system were the highest mismatch rate (0.420),followed by HPA-15 system. It is great significance to establish a local platelet donor bank and provide HPA compatible platelets for patients.
论著

富血小板血浆联合强骨胶囊对大鼠骨质疏松性骨折骨愈合的影响

Effect of platelet rich plasma combined with Qianggu capsule on osteoporotic fracture healing in rats

:1-4
 
目的 研究富血小板血浆联合强骨胶囊对大鼠骨质疏松性骨折骨愈合的影响。方法 80只未交配、3月龄雌性健康SD大鼠作为研究对象,将以上大鼠分为空白组(K组)、PRP组(P组)、强骨胶囊组(Q组),联合组(L组),每组大鼠20例,分析四组大鼠的骨痂显微形态、组织形态学以及生物力学指标之间的差异。结果 经过两两比较,联合用药组患者的骨小梁体积、数量、厚度、连接密度高于单独用药组,分离度、表面积体积比低于对照组(P<0.05);联合用药组患者的最大载荷、结构能量吸收、材料最大应力、材料能量吸收高于单独用药组;经过两两比较,联合用药组患者的骨架面积及软骨或骨性骨痂面积比高于单独用药组。结论 富血小板血浆联合强骨胶囊通过对骨折部位骨质密度以及骨质强度的增强,大鼠骨质疏松性骨折骨愈合情况良好。
Objective To study the effect of platelet rich plasma combined with Qianggu capsule on osteoporotic fracture healing in rats. Methods 80 unmatched and 3-month-old female healthy SD rats were divided into blank group (group K),PrP group (group P),Qianggu capsule group (group Q),combined group (group L) and 20 rats in each group. The differences of callus morphology,histomorphology and biomechanical indexes among the four groups were analyzed. Results After comparing the two groups,the volume,quantity,thickness and connection density of trabecula in the combined group were higher than those in the single drug group,and the separation and surface area volume ratio were lower than those in the control group (P< 0.05); the maximum load,structural energy absorption,material maximum stress and material energy absorption in the combined group were higher than those in the single group; after comparing the two groups,in the combined group,skeleton area and area ratio of cartilage or osteotylus in the treatment group were higher than that in single-drug group. Conclusion Platelet rich plasma combined with Qianggu capsule may enhance the bone density and bone strength of the fracture site,and the osteoporotic fracture healing in rats is good.
出版者信息








《广州医药》公众号